Reorganization of oral anticoagulant (warfarin) treatment follow-up.
OBJECTIVE
To evaluate the impact of the reorganization of oral AC treatment management in a primary healthcare setting in terms of quality of care and cost of care. The evaluated reorganization involved the adoption of an AC nurse service model supported by the use of information and communication technology for storing and handling follow-up data.


METHODS
Statistical analysis of AC follow-up data, personnel task distribution and resource use analysis, and survey of personnel experiences.


METHODS
The Paloheinä health station in Helsinki, Finland.


METHODS
All 122 Paloheinä patients on oral AC treatment and the related Paloheinä personnel. Also, follow-ups from two comparison health stations from Helsinki were used.


METHODS
Laboratory P-INR and follow-up density distributions before and after follow-up reorganization for Paloheinä and comparison station patients, task distribution, and personnel resource use in treatment guideline assignment before and after reorganization and gathered personnel experiences.


RESULTS
No statistically significant changes (Pearson's chi-square test, p < 0.05) were observed in P-INR distributions, considering also the comparison stations. Adoption of the AC nurse model resulted in a 66%/34% task distribution between nurses and physicians in guideline assignment. Personnel resource use analysis showed a cost decrease of 1.61 euros per follow-up in guideline assignment. Users who responded to the survey were generally satisfied with the reorganization and its subjective impacts.


CONCLUSIONS
Reorganization resulted in a potential reduction in cost of care per follow-up without a change in the observed quality of care in the Paloheinä setting. Personnel generally accepted the reorganization.
Niiranen
Samuli
S
Terivan Oy, Tampere, Finland. samuli.niiranen@terivan.com
Wartiovaara-Kautto
Ulla
U
Syrjälä
Martti
M
Puustinen
Raija
R
Yli-Hietanen
Jari
J
Mattila
Heikki
H
Kalli
Seppo
S
Lamminen
Heikki
H
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage* / Q000097:blood; D003151:Community Health Centers / Q000191:economics / Q000458:organization & administration / Q000592:standards; D017046:Cost Savings; D005387:Finland; D005500:Follow-Up Studies; D006801:Humans; D019934:International Normalized Ratio; D016347:Medical Records Systems, Computerized; D009726:Nurses; D010821:Physicians, Family; D017410:Practice Guidelines as Topic; D011795:Surveys and Questionnaires; D014859:Warfarin / Q000008:administration & dosage* / Q000097:blood; D000078329:Workforce
D000925:Anticoagulants; D014859:Warfarin